Can response to treatment predict outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)?

被引:0
作者
Jayavalsan, Shinoj Pattali
Schmidt, Shannon Leah
Durkal, Vipal
Ritch, Paul S.
Thomas, James P.
Erickson, Beth
Christians, Kathleen K.
Tsai, Susan
Evans, Douglas B.
George, Ben
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Froedtert Hosp, Milwaukee, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
443
引用
收藏
页数:1
相关论文
共 50 条
[31]   Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy [J].
Daiki Marukawa ;
Kunihito Gotoh ;
Shogo Kobayashi ;
Kazuki Sasaki ;
Yoshifumi Iwagami ;
Daisaku Yamada ;
Yoshito Tomimaru ;
Hirofumi Akita ;
Tadafumi Asaoka ;
Takehiro Noda ;
Hidenori Takahashi ;
Masahiro Tanemura ;
Yuichiro Doki ;
Hidetoshi Eguchi .
International Journal of Clinical Oncology, 2023, 28 :576-586
[32]   The Peripheral Blood Lymphocyte to Monocyte Ratio Can Predict Mortality in Patients With Pancreatic Adenocarcinoma [J].
Singh, Gurshawn ;
Kim, David D. ;
Zhu, Hong ;
Nassri, Ammar B. ;
Spechler, Stuart J. ;
Huerta, Sergio ;
Ramzan, Zeeshan .
GASTROENTEROLOGY, 2016, 150 (04) :S324-S324
[33]   Endoscopic retrograde cholangiopancreatography (ERCP) findings to predict survival in patients with metastatic pancreatic adenocarcinoma. [J].
Sridharan, Vishwajith ;
Shafique, Neha ;
Darnell, Elijah ;
Wang, Thomas ;
Hernandez-Barco, Yasmin ;
Weniger, Maximilian ;
Qadan, Motaz ;
Del-Castillo, Carlos Fernandez ;
Casey, Brenna ;
Krishnan, Kumar .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[34]   The impact of cigarette smoking on treatment outcome in metastatic pancreatic cancer patients [J].
Ghani, Sofia ;
Jitawatanarat, Potjana ;
Chittawatanarat, Kaweesak ;
Samuel, Sandeep ;
Iyer, Renuka V. ;
Ma, Wen Wee .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[35]   Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma [J].
D'Onofrio, M. ;
Gallotti, A. ;
Mantovani, W. ;
Crosara, S. ;
Manfrin, E. ;
Falconi, M. ;
Ventriglia, A. ;
Zamboni, G. A. ;
Manfredi, R. ;
Mucelli, R. Pozzi .
EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (02) :227-233
[36]   POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC). [J].
Schwartz, Lawrence Howard ;
Kindler, Hedy L. ;
Hammel, Pascal ;
Reni, Michele ;
Van Cutsem, Eric ;
Macarulla, Teresa ;
Hall, Michael J. ;
Park, Joon Oh ;
Hochhauser, Daniel ;
Arnold, Dirk ;
Oh, Do-Youn ;
Reinacher-Schick, Anke ;
Tortora, Giampaolo ;
Alguel, Hana ;
O'Reilly, Eileen Mary ;
Fromageau, Jeremie ;
Ghiorghiu, Dana C. ;
McGuinness, David ;
Locker, Gershon Y. ;
Golan, Talia .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[37]   Early metabolic response as predictor for treatment outcome of pazopanib in patients with metastatic soft tissue sarcomas (the PREDICT study). [J].
Van Der Graaf, Winette T. A. ;
Vlenterie, Myrella ;
Steeghs, Neeltje ;
Desar, Ingrid ;
Verheijen, Remy B. ;
Koenen, Anne Miek ;
Grootjans, Willem ;
de Geus-Oei, Lioe-Fee ;
Oyen, Wim J. G. ;
Van Erp, Nielka P. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[38]   Operability Classifications Predict Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy [J].
Tzeng, C. D. ;
Fleming, J. B. ;
Lee, J. E. ;
Xiao, L. ;
Pisters, P. W. ;
Vauthey, J. ;
Abdalla, E. K. ;
Wolff, R. A. ;
Varadhachary, G. R. ;
Fogelman, D. R. ;
Crane, C. H. ;
Balachandran, A. ;
Katz, M. H. .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 :S152-S152
[39]   POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC). [J].
Schwartz, Lawrence Howard ;
Kindler, Hedy L. ;
Hammel, Pascal ;
Reni, Michele ;
Van Cutsem, Eric ;
Macarulla, Teresa ;
Hall, Michael J. ;
Park, Joon Oh ;
Hochhauser, Daniel ;
Arnold, Dirk ;
Oh, Do-Youn ;
Reinacher-Schick, Anke C. ;
Tortora, Giampaolo ;
Algul, Hana ;
O'Reilly, Eileen Mary ;
Fromageau, Jeremie ;
Ghiorghiu, Dana C. ;
McGuinness, David ;
Locker, Gershon Y. ;
Golan, Talia .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[40]   GEMOX PLUS ERLOTINIB FOR THE TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA [J].
Fuereder, T. ;
Kornek, G. V. ;
Kuehrer, I. ;
Zielinski, C. ;
Klech, J. ;
Scheithauer, W. .
ANNALS OF ONCOLOGY, 2012, 23 :253-253